-
2
-
-
0033013527
-
The London fibromyalgia study: The prevalence of fibromyalgia syndrome in London, Ontario
-
White KP, Speechley M, Harth M, et al. The London fibromyalgia study: The prevalence of fibromyalgia syndrome in London, Ontario. J Rheumatol 1999;26:1570-6.
-
(1999)
J Rheumatol
, vol.26
, pp. 1570-1576
-
-
White, K.P.1
Speechley, M.2
Harth, M.3
-
3
-
-
0026747899
-
Towards a model of pathophysiology of fibromyalgia: Aberrant central pain mechanisms with peripheral modulation
-
Yunus MB. Towards a model of pathophysiology of fibromyalgia: Aberrant central pain mechanisms with peripheral modulation. J Rheumatol 1992;19:846-50.
-
(1992)
J Rheumatol
, vol.19
, pp. 846-850
-
-
Yunus, M.B.1
-
4
-
-
0027092651
-
Fibromyalgia syndrome. New associations
-
Waylonis GW, Heck W. Fibromyalgia syndrome. New associations. Am J Phys Med Rehabil 1992;71:343-8.
-
(1992)
Am J Phys Med Rehabil
, vol.71
, pp. 343-348
-
-
Waylonis, G.W.1
Heck, W.2
-
6
-
-
0025828004
-
Toward an integrated understanding of fibromyalgia syndrome. I. Medical and pathophysiological aspects
-
Boissevain MD, McCain GA. Toward an integrated understanding of fibromyalgia syndrome. I. Medical and pathophysiological aspects. Pain 1991;45:227-38.
-
(1991)
Pain
, vol.45
, pp. 227-238
-
-
Boissevain, M.D.1
McCain, G.A.2
-
8
-
-
53549086775
-
Fibromyalgia syndrome: A relevant recent construction of an ancient condition?
-
Perrot S. Fibromyalgia syndrome: A relevant recent construction of an ancient condition? Curr Opin Support Palliat Care 2008;2:122-7.
-
(2008)
Curr Opin Support Palliat Care
, vol.2
, pp. 122-127
-
-
Perrot, S.1
-
9
-
-
47349107934
-
Central nervous system abnormalities in fibromyalgia and chronic fatigue syndrome: New concepts in treatment
-
Gur A, Oktayoglu P. Central nervous system abnormalities in fibromyalgia and chronic fatigue syndrome: New concepts in treatment. Curr Pharm Des 2008;14:1274-94.
-
(2008)
Curr Pharm Des
, vol.14
, pp. 1274-1294
-
-
Gur, A.1
Oktayoglu, P.2
-
11
-
-
0036711111
-
Enhanced temporal summation of second pain and its central modulation in fibromyalgia patients
-
Price DD, Staud R, Robinson ME, et al. Enhanced temporal summation of second pain and its central modulation in fibromyalgia patients. Pain 2002;99:49-59.
-
(2002)
Pain
, vol.99
, pp. 49-59
-
-
Price, D.D.1
Staud, R.2
Robinson, M.E.3
-
12
-
-
23444450943
-
Fibromyalgia syndrome: Review of clinical presentation, pathogenesis, outcome measures, and treatment
-
Mease P. Fibromyalgia syndrome: Review of clinical presentation, pathogenesis, outcome measures, and treatment. J Rheumatol Suppl 2005;75:6-21.
-
(2005)
J Rheumatol Suppl
, vol.75
, pp. 6-21
-
-
Mease, P.1
-
13
-
-
34248636796
-
New insights into the pathogenesis of fibromyalgia syndrome: Important role of peripheral and central pain mechanisms
-
Staud R. New insights into the pathogenesis of fibromyalgia syndrome: Important role of peripheral and central pain mechanisms. Curr Rheumatol Rev 2007;3:113-21.
-
(2007)
Curr Rheumatol Rev
, vol.3
, pp. 113-121
-
-
Staud, R.1
-
14
-
-
34248665817
-
Fibromyalgia and overlapping disorders: The unifying concept of central sensitivity syndromes
-
Yunus MB. Fibromyalgia and overlapping disorders: The unifying concept of central sensitivity syndromes. Semin Arthritis Rheum 2007;36:339-56.
-
(2007)
Semin Arthritis Rheum
, vol.36
, pp. 339-356
-
-
Yunus, M.B.1
-
15
-
-
0642335532
-
Fibromyalgia, hepatitis C infection, and the cytokine connection
-
Thompson ME, Barkhuizen A. Fibromyalgia, hepatitis C infection, and the cytokine connection. Curr Pain Headache Rep 2003;7:342-7.
-
(2003)
Curr Pain Headache Rep
, vol.7
, pp. 342-347
-
-
Thompson, M.E.1
Barkhuizen, A.2
-
16
-
-
33644859724
-
Is there a role for cytokine based therapies in fibromyalgia
-
Wallace DJ. Is there a role for cytokine based therapies in fibromyalgia. Curr Pharm Des 2006;12:17-22.
-
(2006)
Curr Pharm Des
, vol.12
, pp. 17-22
-
-
Wallace, D.J.1
-
17
-
-
34249803311
-
Cytokine patterns in fibromyalgia and their correlation with clinical manifestations
-
Bazzichi L, Rossi A, Massimetti G, et al. Cytokine patterns in fibromyalgia and their correlation with clinical manifestations. Clin Exp Rheumatol 2007;25:225-30.
-
(2007)
Clin Exp Rheumatol
, vol.25
, pp. 225-230
-
-
Bazzichi, L.1
Rossi, A.2
Massimetti, G.3
-
18
-
-
20244389715
-
Pregabalin for the treatment of fibromyalgia syndrome: Results of a randomized, double-blind, placebo-controlled trial
-
Crofford LJ, Rowbotham MC, Mease PJ, et al. Pregabalin for the treatment of fibromyalgia syndrome: Results of a randomized, double-blind, placebo-controlled trial. American College of Rheumatology 2005;52:1264-73.
-
(2005)
American College of Rheumatology
, vol.52
, pp. 1264-1273
-
-
Crofford, L.J.1
Rowbotham, M.C.2
Mease, P.J.3
-
19
-
-
4444381930
-
A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder
-
Arnold LM, Lu Y, Crofford LJ, et al. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder. Arthritis Rheum 2004;50:2974-84.
-
(2004)
Arthritis Rheum
, vol.50
, pp. 2974-2984
-
-
Arnold, L.M.1
Lu, Y.2
Crofford, L.J.3
-
20
-
-
26444518188
-
Efficacy of milnacipran in patients with fibromyalgia
-
Gendreau RM, Thorn MD, Gendreau JF, et al. Efficacy of milnacipran in patients with fibromyalgia. J Rheumatol 2005;32:1975-85.
-
(2005)
J Rheumatol
, vol.32
, pp. 1975-1985
-
-
Gendreau, R.M.1
Thorn, M.D.2
Gendreau, J.F.3
-
21
-
-
58849097195
-
Fibromyalgia: A review of its pathophysiology and drug treatment
-
Krypel LL. Fibromyalgia: A review of its pathophysiology and drug treatment. J Pharm Pract 2009;22:6-16.
-
(2009)
J Pharm Pract
, vol.22
, pp. 6-16
-
-
Krypel, L.L.1
-
22
-
-
41549092667
-
Pharmacological treatments of fibromyalgia: Do complex conditions need complex therapies?
-
Lawson K. Pharmacological treatments of fibromyalgia: Do complex conditions need complex therapies? Drug Discov Today 2008;13:333-40.
-
(2008)
Drug Discov Today
, vol.13
, pp. 333-340
-
-
Lawson, K.1
-
23
-
-
0037209098
-
Neuroprotective effect of naloxone in inflammation-mediated dopaminergic neurodegeneration: Dissociation from the involvement of opioid receptors
-
Liu B, Hong JS. Neuroprotective effect of naloxone in inflammation-mediated dopaminergic neurodegeneration: Dissociation from the involvement of opioid receptors. Methods Mol Med 2002;79:43-54.
-
(2002)
Methods Mol Med
, vol.79
, pp. 43-54
-
-
Liu, B.1
Hong, J.S.2
-
24
-
-
0034072541
-
Reduction by naloxone of lipopolysaccharide-induced neurotoxicity in mouse cortical neuron-glia co-cultures
-
Liu B, Du L, Kong L-Y, et al. Reduction by naloxone of lipopolysaccharide-induced neurotoxicity in mouse cortical neuron-glia co-cultures. Neuroscience 2000;97:749-56.
-
(2000)
Neuroscience
, vol.97
, pp. 749-756
-
-
Liu, B.1
Du, L.2
Kong, L.-Y.3
-
25
-
-
0027527271
-
Peripheral mechanisms of opioid antinociception in inflammation: Involvement of cytokines
-
Czlonkowski A, Stein C, Harz A. Peripheral mechanisms of opioid antinociception in inflammation: Involvement of cytokines. Eur J Pharmacol 1993;242:229-35.
-
(1993)
Eur J Pharmacol
, vol.242
, pp. 229-235
-
-
Czlonkowski, A.1
Stein, C.2
Harz, A.3
-
26
-
-
3242717651
-
The opioid antagonist naltrexone blocks acute endotoxic shock by inhibiting tumor necrosis factor-alpha production
-
Greeneltch KM, Haudenschild CC, Keegan AD, et al. The opioid antagonist naltrexone blocks acute endotoxic shock by inhibiting tumor necrosis factor-alpha production. Brain Behav Immun 2004;18:476-84.
-
(2004)
Brain Behav Immun
, vol.18
, pp. 476-484
-
-
Greeneltch, K.M.1
Haudenschild, C.C.2
Keegan, A.D.3
-
27
-
-
0034015558
-
Naloxone protects rat dopaminergic neurons against inflammatory damage through inhibition of microglia activation and superoxide generation
-
Liu B, Du L, Hong JS. Naloxone protects rat dopaminergic neurons against inflammatory damage through inhibition of microglia activation and superoxide generation. J Pharmacol Exp Ther 2000;293:607-17.
-
(2000)
J Pharmacol Exp Ther
, vol.293
, pp. 607-617
-
-
Liu, B.1
Du, L.2
Hong, J.S.3
-
28
-
-
51749085166
-
Ultra-low-dose naloxone restores the antinociceptive effect of morphine and suppresses spinal neuroinflammation in PTX-treated rats
-
Tsai RY, Jang FL, Tai YH, et al. Ultra-low-dose naloxone restores the antinociceptive effect of morphine and suppresses spinal neuroinflammation in PTX-treated rats. Neuropsychopharmacology 2008;33:2772-82.
-
(2008)
Neuropsychopharmacology
, vol.33
, pp. 2772-2782
-
-
Tsai, R.Y.1
Jang, F.L.2
Tai, Y.H.3
-
29
-
-
0033810830
-
Systemic infusion of naloxone reduces degeneration of rat substantia nigral dopaminergic neurons induced by intranigral injection of lipopolysaccharide
-
Liu B, Jiang JW, Wilson BC, et al. Systemic infusion of naloxone reduces degeneration of rat substantia nigral dopaminergic neurons induced by intranigral injection of lipopolysaccharide. J Pharmacol Exp Ther 2000;295:125-32.
-
(2000)
J Pharmacol Exp Ther
, vol.295
, pp. 125-132
-
-
Liu, B.1
Jiang, J.W.2
Wilson, B.C.3
-
30
-
-
54049124717
-
Non-stereoselective reversal of neuropathic pain by naloxone and naltrexone: Involvement of toll-like receptor 4 (TLR4)
-
Hutchinson MR, Zhang Y, Brown K, et al. Non-stereoselective reversal of neuropathic pain by naloxone and naltrexone: Involvement of toll-like receptor 4 (TLR4). European Journal of Neuroscience 2008;28:20-9.
-
(2008)
European Journal of Neuroscience
, vol.28
, pp. 20-29
-
-
Hutchinson, M.R.1
Zhang, Y.2
Brown, K.3
-
31
-
-
33745747088
-
Modulation of brain apoptosis-related proteins by the opioid antagonist naltrexone in mice
-
San-Emeterio EP, Hurlé MA. Modulation of brain apoptosis-related proteins by the opioid antagonist naltrexone in mice. Neurosci Lett 2006;403:276-9.
-
(2006)
Neurosci Lett
, vol.403
, pp. 276-279
-
-
San-Emeterio, E.P.1
Hurlé, M.A.2
-
32
-
-
0028895234
-
Treatment of neurotoxic side effects of interferon-alpha with naltrexone
-
Valentine AD, Meyers CA, Talpaz M. Treatment of neurotoxic side effects of interferon-alpha with naltrexone. Cancer Invest 1995;13:561-6.
-
(1995)
Cancer Invest
, vol.13
, pp. 561-566
-
-
Valentine, A.D.1
Meyers, C.A.2
Talpaz, M.3
-
33
-
-
33947666146
-
Low-dose naltrexone therapy improves active Crohn's disease
-
Smith JP, Stock H, Bigaman S, et al. Low-dose naltrexone therapy improves active Crohn's disease. Am J of Gastroenterol 2007;102:820-8.
-
(2007)
Am J of Gastroenterol
, vol.102
, pp. 820-828
-
-
Smith, J.P.1
Stock, H.2
Bigaman, S.3
-
34
-
-
58149337463
-
A pilot trial of low-dose naltrexone in primary progressive multiple sclerosis
-
Gironi M, Martinelli-Boneschi F, Sacerdote P, et al. A pilot trial of low-dose naltrexone in primary progressive multiple sclerosis. Mult Scler 2008;14:1076-83.
-
(2008)
Mult Scler
, vol.14
, pp. 1076-1083
-
-
Gironi, M.1
Martinelli-Boneschi, F.2
Sacerdote, P.3
-
35
-
-
0025266660
-
The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: Report of the Multicenter Criteria Committee
-
Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: Report of the Multicenter Criteria Committee. Arthritis Rheum 1990;33:160-72.
-
(1990)
Arthritis Rheum
, vol.33
, pp. 160-172
-
-
Wolfe, F.1
Smythe, H.A.2
Yunus, M.B.3
-
36
-
-
1642380769
-
Is a single-item visual analogue scale as valid, reliable, and responsive as multi-item scales in measuring quality of life?
-
de Boer AGEM, van Lanschot JJB, Stalmeier PFM, et al. Is a single-item visual analogue scale as valid, reliable, and responsive as multi-item scales in measuring quality of life? Qual Life Res 2004;13:311-20.
-
(2004)
Qual Life Res
, vol.13
, pp. 311-320
-
-
de Boer, A.G.E.M.1
van Lanschot, J.J.B.2
Stalmeier, P.F.M.3
-
37
-
-
0026165648
-
The fibromyalgia impact questionnaire: Development and validation
-
Burckhardt CS, Clark SR, Bennett RM. The fibromyalgia impact questionnaire: Development and validation. J Rheumatol 1991;18:728-33.
-
(1991)
J Rheumatol
, vol.18
, pp. 728-733
-
-
Burckhardt, C.S.1
Clark, S.R.2
Bennett, R.M.3
-
38
-
-
0035733108
-
The control of false discovery rate under dependency
-
Bejamini Y, Yekutieli D. The control of false discovery rate under dependency. Ann Stat 2001;29:1165-88.
-
(2001)
Ann Stat
, vol.29
, pp. 1165-1188
-
-
Bejamini, Y.1
Yekutieli, D.2
-
39
-
-
33749238682
-
Beyond Bonferroni: Less conservative analyses for conservation genetics
-
Narum SR. Beyond Bonferroni: Less conservative analyses for conservation genetics. Conserv Genet 2006;7:783-7.
-
(2006)
Conserv Genet
, vol.7
, pp. 783-787
-
-
Narum, S.R.1
-
40
-
-
0034748159
-
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale
-
Farrar JT, Young JP, LaMoreaux L, et al. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 2001;94:149-58.
-
(2001)
Pain
, vol.94
, pp. 149-158
-
-
Farrar, J.T.1
Young, J.P.2
LaMoreaux, L.3
-
41
-
-
34547145165
-
G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences
-
Faul F, Erdfelder E, G Lang A-G, Buchner A. G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 2007;39:175-91.
-
(2007)
, vol.39
, pp. 175-191
-
-
Faul, F.1
Erdfelder, E.G.2
Lang, A.-G.3
Buchner, A.4
-
42
-
-
0027207366
-
Pain intensity in patients with fibromyalgia and rheumatoid arthritis
-
Viitanen JV, Kautiainen H, Isomäki H. Pain intensity in patients with fibromyalgia and rheumatoid arthritis. Scand J Rheumatol 1993;22:131-5.
-
(1993)
Scand J Rheumatol
, vol.22
, pp. 131-135
-
-
Viitanen, J.V.1
Kautiainen, H.2
Isomäki, H.3
-
43
-
-
10444286617
-
The DAS28 in rheumatoid arthritis and fibromyalgia patients
-
Leeb BF, Andel I, Sautner J, et al. The DAS28 in rheumatoid arthritis and fibromyalgia patients. Rheumatology 2004;43:1504-7.
-
(2004)
Rheumatology
, vol.43
, pp. 1504-1507
-
-
Leeb, B.F.1
Andel, I.2
Sautner, J.3
-
44
-
-
33845866350
-
The frequency of thyroid antibodies in fibromyalgia patients and their relationship with symptoms
-
Pamuk Ö, Çakir N. The frequency of thyroid antibodies in fibromyalgia patients and their relationship with symptoms. Clin Rheumatol 2007;26:55-9.
-
(2007)
Clin Rheumatol
, vol.26
, pp. 55-59
-
-
Pamuk, Ö.1
Çakir, N.2
-
45
-
-
0142040426
-
Subgrouping of fibromyalgia patients on the basis in pressure-pain thresholds and psychological factors
-
Giesecke T, Williams DA, Harris RE. Subgrouping of fibromyalgia patients on the basis in pressure-pain thresholds and psychological factors. Arthritis Rheum 2003;48:2916-22.
-
(2003)
Arthritis Rheum
, vol.48
, pp. 2916-2922
-
-
Giesecke, T.1
Williams, D.A.2
Harris, R.E.3
-
46
-
-
0037980445
-
Economic cost and epidemiological characteristics of patients with fibromyalgia claims
-
Robinson RL, Birnbaum HG, Morley MA, et al. Economic cost and epidemiological characteristics of patients with fibromyalgia claims. J Rheum 2003;30:1318-25.
-
(2003)
J Rheum
, vol.30
, pp. 1318-1325
-
-
Robinson, R.L.1
Birnbaum, H.G.2
Morley, M.A.3
-
47
-
-
3042806295
-
Direct and indirect costs of fibromyalgia in women
-
Penrod J, Adam V, Bernatsky S, et al. Direct and indirect costs of fibromyalgia in women. J Rheum 2004;31:1391-8.
-
(2004)
J Rheum
, vol.31
, pp. 1391-1398
-
-
Penrod, J.1
Adam, V.2
Bernatsky, S.3
-
48
-
-
0009538663
-
Naltrexone and hepatotoxicity
-
Mitchell JE. Naltrexone and hepatotoxicity. Lancet 1986;1:1215.
-
(1986)
Lancet
, vol.1
, pp. 1215
-
-
Mitchell, J.E.1
-
50
-
-
34548201190
-
The high affinity peripheral benzodiazepine receptor ligand DAA1106 binds specifically to microglia in a rat model of traumatic brain injury: Implications for PET imaging
-
Venneti S, Wagner AK, Wang G, et al. The high affinity peripheral benzodiazepine receptor ligand DAA1106 binds specifically to microglia in a rat model of traumatic brain injury: Implications for PET imaging. Exp Neurol 2007;207:118-27.
-
(2007)
Exp Neurol
, vol.207
, pp. 118-127
-
-
Venneti, S.1
Wagner, A.K.2
Wang, G.3
|